AIM ImmunoTech's market cap is currently $9.82M. The company's EPS TTM is $-0.472; its P/E ratio is ―; AIM ImmunoTech is scheduled to report earnings on April 7, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 202.00K	$ 141.00K	$ 135.00K	$ 163.00K	$ 140.00K
Gross Profit	$ 160.00K	$ -19.78M	$ -715.00K	$ -643.00K	$ -753.00K
Operating Income	$ -31.92M	$ -19.92M	$ -18.84M	$ -15.15M	$ -12.44M
EBITDA	$ -31.68M	$ -19.87M	$ -18.25M	$ -13.02M	$ -8.15M
Net Income	$ -28.96M	$ -21.09M	$ -21.51M	$ -16.26M	$ -10.83M
Balance Sheet
Cash & Short-Term Investments	$ 13.07M	$ 34.19M	$ 48.27M	$ 39.00M	$ 8.78M
Total Assets	$ 19.38M	$ 40.49M	$ 57.70M	$ 64.58M	$ 20.22M
Total Debt	$ 718.00K	$ 837.00K	$ 149.00K	$ 2.29M	$ 6.38M
Net Debt	$ -4.72M	$ -26.22M	$ -31.94M	$ -36.22M	$ 4.91M
Total Liabilities	$ 9.15M	$ 2.02M	$ 820.00K	$ 3.29M	$ 7.31M
Stockholders' Equity	$ 10.23M	$ 38.47M	$ 56.88M	$ 61.29M	$ 12.91M
Cash Flow
Free Cash Flow	$ -21.85M	$ -16.38M	$ -14.60M	$ -10.96M	$ -9.43M
Operating Cash Flow	$ -21.27M	$ -16.11M	$ -13.96M	$ -10.37M	$ -9.07M
Investing Cash Flow	$ -832.00K	$ 10.99M	$ -631.00K	$ -9.16M	$ -6.15M
Financing Cash Flow	$ 485.00K	$ 80.00K	$ 8.19M	$ 56.56M	$ 16.39M

Currency in USD

AIM ImmunoTech Earnings and Revenue History

Income Statement >

AIM ImmunoTech Debt to Assets

Balance Sheet >

AIM ImmunoTech Cash Flow

Cash Flow >

AIM ImmunoTech Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing